[1]
2025. Immunogenicity Assay Cut-Point Drift Across a Multi-Year Programme: A Short Communication. Translational Medicine & Therapeutics Journal. 4, 2 (Oct. 2025), 83–91. DOI:https://doi.org/10.5281/zenodo.22649429.